Exagen Inc. buy BiotechBee
Start price
02.12.23
/
50%
€2.70
Target price
31.12.25
€2.60
Performance (%)
-
End price
04.12.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Exagen Inc. | - | - |
iShares Core DAX® | 1.665% | 1.692% |
iShares Nasdaq 100 | -0.475% | 1.483% |
iShares Nikkei 225® | 2.620% | 4.475% |
iShares S&P 500 | -0.091% | 1.099% |
According to BiotechBee what are the pros and cons of Exagen Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Exagen Inc. diskutieren
Buy mit Kursziel 2,6
In the thread Trading Exagen Inc.
Buy beendet